Immunoexpression of P16 and Ki 67 in oral squamous cell carcinoma: Association with clinicopathological parameters.
Background and Objectives: Oral squamous cell carcinoma (OSCC) is considered as a major health problem worldwide and has been associated with high recurrence rate and poor prognosis. Advances in understanding of OSCC have not improved the outcome in their management significantly. Many studies have focused on the roles of biomolecular markers in OSCC. The use of p16 and Ki67 as biomarkers of biological behavior of oral squamous cell carcinoma is contro-versial. This study aimed to determine immunoexpression of P16 and Ki67 in oral squamous cell carcinoma and to evaluate their association with various clinicopathological parameters.
Materials and Methods: Fifty cases of squamous cell carcinoma from different locations in the oral cavity were included in this cross sectional study. The cases were collected from Rizgary Teaching Hospital and Private Laboratories in Erbil city during a period of eight months from October 2018 to May 2019. The expression of p16 and Ki 67 were evaluated immunohistochemically; the findings were correlated with the age of the patients, gender, site of the tumor and grade of the tumor.
Result: A total of 50 patients with oral squamous cell carcinoma were enrolled in this study the age ranged from 33 to 89 years, with a mean age ± SD of (64.24 ±12.01) years and more than half (52.0%) of them were males. Lower lip was the most common site of the tumor followed by upper lip and tongue (42.0%, 26.0% and 18.0%, respectively). Histopathological findings of the tumor showed that (54.0%) of the patients had moderately differentiated squamous cell carcinoma. However, (84.0%) of the patients showed negative expression of P 16, while Ki 67 expression was positive among (76.0%) of them. No significant statistical association were found between immunoexpression of p16 and age, sex of patient, site of the tumor and grade of the tumor (P=0.67, P=0,095, P=0.696, P=0.454 respectively). No significant statistical association were found between immunoexpression of Ki67 and age, sex of patient, site of the tumor and grade of the tumor (P=0.637, P=0,411, P=0.353, P=1.00 respectively).
Conclusion: in relation to the results obtained in this study no significant association were found between P16 and Ki 67 immunoexpression in oral squamous cell carcinoma with clinicopathological parameters. Further researches have to be designed to better understand the role of p16 and Ki 67 in OSCC.
Abrahao AC, Bonelli BV, Nunes FD, Dias EP, Cabral MG. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders. Braz Oral Res 2011;25(1):34-41.
Barnes L, Eveson J, Reichart P, Sidransky D. World Health Organization classification of tumours: pathology and genetics of head and neck tu-mours. 2005.
Bradley KT, Budnick SD, Logani S. Immunohisto-chemical detection of p16 INK4a in dysplastic lesions of the oral cavity. Modern pathology 2006;19(10):1310.
de Spíndula-Filho JV, Da Cruz AD, Oton-Leite AF, Batista AC, Leles CR, Alencar RdCG, et al. Oral squamous cell carcinoma versus oral verrucous carcinoma: an approach to cellular proliferation and negative relation to human papillomavirus (HPV). Tumor Biology 2011;32(2):409-16.
Fazeli Z, Pourhoseingholi MA, Pourhoseingholi A, Vahedi M, Zali MR. Mortality of oral cavity cancer in Iran. Asian Pac J Cancer Prev 2011;12(10).
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J of cancer 2010;127(12):2893-917.
Hopman AH, Smedts F, Dignef W, Ummelen M, Sonke G, Mravunac M, et al. Transition of high‐grade cervical intraepithelial neoplasia to micro‐invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnor-malities. J of the Pathol Society of Great Britain and Ireland. 2004;202(1):23-33.
Li Z, Wang Y, Yuan C, Zhu Y, Qiu J, Zhang W, et al. Oncogenic roles of Bmi1 and its therapeutic inhi-bition by histone deacetylase inhibitor in tongue cancer. Laboratory investigation 2014;94(12):1431.
Linxweiler M, Bochen F, Wemmert S, Lerner C, Hasenfus A, Bohle RM, et al. Combination of p16INK4a/Ki67 immunocytology and hpv poly-merase chain reaction for the noninvasive analy-sis of HPV involvement in head and neck cancer. Cancer cytopathology 2015;123(4):219-29.
Mikami T, Cheng J, Maruyama S, Kobayashi T, Funayama A, Yamazaki M, et al. Emergence of keratin 17 vs. loss of keratin 13: their reciprocal immunohistochemical profiles in oral carcinoma in situ. Oral oncology 2011;47(6):497-503.
Reuschenbach M, Seiz M, Doeberitz CvK, Vinoku-rova S, Duwe A, Ridder R, et al. Evaluation of cer-vical cone biopsies for coexpression of p16INK4a and Ki‐67 in epithelial cells. Int J of cancer 2012;130(2):388-94.
Rosai J. Rosai and Ackerman's surgical pathology. 10thed, volume one, USA, Elsevier, Mosby, 2011: 65.
Sritippho T, Chotjumlong P, Iamaroon A. Roles of human papillomaviruses and p16 in oral cancer. Asian Pac J Cancer Prev 2015;16(15):6193-200.
Warnakulasuriya S, Kovacevic T, Madden P, Cou-pland V, Sperandio M, Odell E, et al. Factors pre-dicting malignant transformation in oral poten-tially malignant disorders among patients ac-crued over a 10‐year period in South East Eng-land. J of oral pathology & medicine 2011;40(9):677-83.
Yan J, Liu X-L, Han L-Z, Xiao G, Li N-L, Deng Y-N, et al. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis. Asian Pac J Cancer Prev 2015;16(2):823-9.
Yu L-L, Guo H-Q, Lei X-Q, Qin Y, Wu Z-N, Kang L-N, et al. p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervi-cal histopathology: a 3-year cohort study in Chi-na. Oncotarget 2016;7(40):64810.
Akrish S, Ben-Izhak O, Sabo E, Rachmiel A. Oral squamous cell carcinoma associated with prolif-erative verrucous leukoplakia compared with conventional squamous cell carcinoma—a clini-cal, histologic and immunohistochemical study. Oral surgery, oral medicine, oral pathology and oral radiology 2015;119(3):318-25.
Shailaja G, Kumar JV, Baghirath P, Kumar U, Ashalata G, Krishna AB. Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohisto-chemical expression of Ki-67, p53, BCL-2, and BAX markers. Dental research J 2015;12(3):235.
Gonzalez JCC, Cepeda LAG, Yanez SAB, Cornejo AD, Estevez ADM, Huerta ERL. p53 and p16 in oral epithelial dysplasia and oral squamous cell carcinoma: A study of 208 cases. Indian J of Pa-thology and Microbiology 2016;59(2):153.
Vallonthaiel AG, Singh MK, Dinda AK, Kakkar A, Thakar A, Das SN. Expression of cell cycle-associated proteins p53, pRb, p16, p27, and cor-relation with survival: a comparative study on oral squamous cell carcinoma and verrucous car-cinoma. Applied Immunohistochemistry & Molec-ular Morphology 2016;24(3):193-200.
dos Santos Costa SF, Brennan PA, Gomez RS, Fregnani ER, Santos‐Silva AR, Martins MD, et al. Molecular basis of oral squamous cell carcinoma in young patients: Is it any different from older patients? J of Oral Pathology & Medicine 2018;47(6):541-6.
Rosa EA, Hurtado‑Puerto AM, Falcão DP, Brietz-ke AP, de Almeida Prado Franceschi LE, Neto C, etal. Oral lichen planus and malignant transfor-mation: The role of p16, Ki-67, Bub-3 and SOX4 in assessing precancerous potential. Experimental and therapeutic medicine 2018;15(5):4157-66.
Sharada P, Swaminathan U, Nagamalini B, Vinod-kumar K, Ashwini B, Lavanya V. A Semi-quantitative analysis of immunohistochemical expression of p63, Ki-67, Cyclin-D1, and p16 in common oral potentially malignant disorders and oral squamous cell carcinoma. J of Dr NTR Uni-versity of Health Sciences 2018;7(2):120.
Beevi BH, Nayak SR, Peter CD, Haridas AK, Jacob L, Aboobakker A. Analysis of Ki-67 expression in oral premalignant lesions and normal oral muco-sa: An immunohistochemical study. J of Pharma-cy & Bioallied Sciences 2019;11( 2):232.
Ciesielska U, Zatonski T, Nowinska K, Ratajczak-Wielgomas K, Grzegrzolka J, Piotrowska A, et al. Expression of cell cycle-related proteins p16, p27 and Ki-67 proliferating marker in laryngeal squa-mous cell carcinomas and in laryngeal papillo-mas. Anticancer research 2017;37(5):2407-15.
Sundberg J, Korytowska M, Burgos PM, Blomgren J, Blomstrand L, De Lara S, et al. Com-bined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell Carcinoma. Anticancer research 2019;39(3):1293-300.
Maebayashi T, Ishibashi N, Aizawa T, Sakaguchi M, Saito T, Kawamori J, et al. Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology 2019:1-9.
Dragomir LP, Simionescu C, Margaritescu C, Ste-pan A, Dragomir IM,Popescu MR. p53, p16 and Ki‑67 immunoexpression in oral squamous carci-nomas. Rom J Morphol Embryol 2012;53:89‑93.
Westra HW. The Changing Face of Head and Neck Cancer in the 21st Century: The Impact of HPV on the Epidemiology and Pathology of Oral Cancer. Head and Neck Pathol 2009; 3:78–81.
Curado MP. dan Hashibe, M. Recent changes in the epidemiology of head and neck cancer. Curr.Opin.Oncol 2009:21, (3) 194-200.
Ampur OY, Sudarsa IW, Suryawisesa IB. Associa-tion of p16 expression with clinicopathological features of oral cavity squamous cell carcinoma patients in Bali. Bali Med J 2016; 5(3): 362-366.
Ralli M, Singh S, Yadav1 S.P.S., Sharma N. et al. Assessment and clinico-pathological correlation of p16 expression in head and neck squamous cell carcinoma. J of Cancer Research and Thera-peutics 2016 ;12 (1):232-7.
Fregonesi P. A, Teresa D. B, Duarte R. A, et al. p16INK4A Immunohistochemical Overexpression in Premalignant and Malignant Oral Lesions Infections.
Copyright (c) 2020 Shadan Mohamad Omer, Payam Anwar Rashid (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.